Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, Peter N. Ray et al.|Journal of Clinical Oncology|2013Cited by 488
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursAndré O. von Bueren, Stefan Rutkowski|British Journal of Cancer|2012Cited by 46
Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocolNicolas Waespe, Marc Ansari, Sven Strebel et al.|BMJ Open|2022Cited by 8
Parental employment adjustment during and after childhood cancer treatment — a report from the Swiss Childhood Cancer Survivor Study-ParentsMartina Ospelt, Gisela Michel, Sonja Kälin et al.|Supportive Care in Cancer|2025Cited by 0